Brief: Daré Bioscience Announces Commencement Of Phase 3 Study Of Ovaprene

Dare Bioscience

04/12/2023 15:17

Dec 4 (Reuters) - Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES COMMENCEMENT OF PHASE 3 STUDY OF
OVAPRENE®, AN INVESTIGATIONAL HORMONE-FREE MONTHLY INTRAVAGINAL
CONTRACEPTIVE

Source text for Eikon:  ID:nGNX4CltBZ 
Further company coverage:  DARE.O 

 ((reuters.briefs@thomsonreuters.com;))